In another study, a whole exome sequencing-based analysis demonstrates that genomic events (mutation and amplification) targeting cell cycle-related genes, including CDKN2A, RB1 and TP53, are associated with GIST progression to malignant disease [37]. The gene discussed is TP53; the disease is gastrointestinal stromal tumor.